{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:36:58Z","timestamp":1775579818375,"version":"3.50.1"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Drug response prediction in cancer cell lines is of great significance in personalized medicine. In this study, we propose GADRP, a cancer drug response prediction model based on graph convolutional networks (GCNs) and autoencoders (AEs). We first use a stacked deep AE to extract low-dimensional representations from cell line features, and then construct a sparse drug cell line pair (DCP) network incorporating drug, cell line, and DCP similarity information. Later, initial residual and layer attention-based GCN (ILGCN) that can alleviate over-smoothing problem is utilized to learn DCP features. And finally, fully connected network is employed to make prediction. Benchmarking results demonstrate that GADRP can significantly improve prediction performance on all metrics compared with baselines on five datasets. Particularly, experiments of predictions of unknown DCP responses, drug-cancer tissue associations\uff0c and drug-pathway associations illustrate the predictive power of GADRP. All results highlight the effectiveness of GADRP in predicting drug responses, and its potential value in guiding anti-cancer drug selection.<\/jats:p>","DOI":"10.1093\/bib\/bbac501","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:43:25Z","timestamp":1670039005000},"source":"Crossref","is-referenced-by-count":31,"title":["GADRP: graph convolutional networks and autoencoders for cancer drug response prediction"],"prefix":"10.1093","volume":"24","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[{"name":"Hunan University College of Computer Science and Electronic Engineering, , Changsha 410082 , China"}]},{"given":"Chong","family":"Dai","sequence":"additional","affiliation":[{"name":"Beijing University of Chemical Technology College of Life Science and Technology, , Beijing 100029 , China"},{"name":"Beijing Institute of Health Service and Transfusion Medicine Department of Bioinformatics, , Beijing 100850 , China"}]},{"given":"Yuqi","family":"Wen","sequence":"additional","affiliation":[{"name":"Beijing Institute of Health Service and Transfusion Medicine Department of Bioinformatics, , Beijing 100850 , China"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Hunan University College of Computer Science and Electronic Engineering, , Changsha 410082 , China"}]},{"given":"Wenjuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan University College of Computer Science and Electronic Engineering, , Changsha 410082 , China"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[{"name":"Beijing Institute of Health Service and Transfusion Medicine Department of Bioinformatics, , Beijing 100850 , China"}]},{"given":"Xiaochen","family":"Bo","sequence":"additional","affiliation":[{"name":"Beijing Institute of Health Service and Transfusion Medicine Department of Bioinformatics, , Beijing 100850 , China"}]},{"given":"Shaoliang","family":"Peng","sequence":"additional","affiliation":[{"name":"Hunan University College of Computer Science and Electronic Engineering, , Changsha 410082 , China"},{"name":"Hunan University The State Key Laboratory of Chemo\/Biosensing and Chemometrics, , Changsha 410082 , China"}]}],"member":"286","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"3","key":"2023011917135403000_ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"2023011917135403000_ref2","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1093\/bioinformatics\/btab466","article-title":"Predicting anti-cancer drug response by finding optimal subset of drugs","volume":"37","author":"Meybodi","year":"2021","journal-title":"Bioinformatics"},{"issue":"2","key":"2023011917135403000_ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212108","article-title":"Drug sensitivity prediction with high-dimensional mixture regression","volume":"14","author":"Li","year":"2019","journal-title":"PloS One"},{"issue":"7391","key":"2023011917135403000_ref4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"D1","key":"2023011917135403000_ref5","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2023011917135403000_ref6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"issue":"10","key":"2023011917135403000_ref7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The nci60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2023011917135403000_ref8","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab393","article-title":"Representation of molecules for drug response prediction","volume":"23","author":"An","year":"2022","journal-title":"Brief Bioinform"},{"issue":"1","key":"2023011917135403000_ref9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/bib\/bbz171","article-title":"Deep learning for drug response prediction in cancer","volume":"22","author":"Baptista","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023011917135403000_ref10","first-page":"1","volume-title":"2019 IEEE Biomedical Circuits and Systems Conference (BioCAS)","author":"Zhao","year":"2019"},{"issue":"11","key":"2023011917135403000_ref11","first-page":"1","article-title":"Network-based drug sensitivity prediction","volume":"13","author":"Ahmed","year":"2020","journal-title":"BMC Med Genomics"},{"issue":"2","key":"2023011917135403000_ref12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1109\/TCBB.2019.2919581","article-title":"Deepdsc: a deep learning method to predict drug sensitivity of cancer cell lines","volume":"18","author":"Li","year":"2019","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"1","key":"2023011917135403000_ref13","first-page":"1","article-title":"Cancer drug response profile scan (CDRSCAN): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"2023011917135403000_ref14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1109\/TCBB.2021.3060430","article-title":"Graph convolutional networks for drug response prediction","volume":"19","author":"Nguyen","year":"2021","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"Supplement_2","key":"2023011917135403000_ref15","doi-asserted-by":"crossref","first-page":"i911","DOI":"10.1093\/bioinformatics\/btaa822","article-title":"Deepcdr: a hybrid graph convolutional network for predicting cancer drug response","volume":"36","author":"Liu","year":"2020","journal-title":"Bioinformatics"},{"issue":"1","key":"2023011917135403000_ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77486-0","article-title":"Adrml: anticancer drug response prediction using manifold learning","volume":"10","author":"Moughari","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"2023011917135403000_ref17","doi-asserted-by":"crossref","first-page":"bbab457","DOI":"10.1093\/bib\/bbab457","article-title":"Graphcdr: a graph neural network method with contrastive learning for cancer drug response prediction","volume":"23","author":"Liu","year":"2022","journal-title":"Brief Bioinform"},{"issue":"3","key":"2023011917135403000_ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"2023011917135403000_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1492-6","article-title":"Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection","volume":"15","author":"Dong","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"2023011917135403000_ref20","first-page":"1","article-title":"Inferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"2023011917135403000_ref21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186906","article-title":"Open source machine-learning algorithms for the prediction of optimal cancer drug therapies","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2023011917135403000_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-11665-4","article-title":"Heterogeneity aware random forest for drug sensitivity prediction","volume":"7","author":"Rahman","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"2023011917135403000_ref23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"Costello","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2023011917135403000_ref24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fgene.2020.00075","article-title":"Dsplmf: a method for cancer drug sensitivity prediction using a novel regularization approach in logistic matrix factorization","volume":"11","author":"Emdadi","year":"2020","journal-title":"Front Genet"},{"key":"2023011917135403000_ref25","article-title":"Artificial intelligence for drug response prediction in disease models","volume":"23","author":"Ballester","journal-title":"Brief Bioinform"},{"issue":"14","key":"2023011917135403000_ref26","doi-asserted-by":"crossref","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","article-title":"Moli: multi-omics late integration with deep neural networks for drug response prediction","volume":"35","author":"Sharifi-Noghabi","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"2023011917135403000_ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-2910-6","article-title":"Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2023011917135403000_ref28","article-title":"Paccmann: prediction of anticancer compound sensitivity with multi-modal attention-based neural networks","author":"Oskooei","year":"2018"},{"issue":"1","key":"2023011917135403000_ref29","first-page":"1","article-title":"Towards a universal smiles representation-a standard method to generate canonical smiles based on the inchi","volume":"4","author":"O\u2019Boyle","year":"2012","journal-title":"J Chem"},{"issue":"3","key":"2023011917135403000_ref30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1109\/JBHI.2021.3102186","article-title":"Predicting drug response based on multi-omics fusion and graph convolution","volume":"26","author":"Peng","year":"2021","journal-title":"IEEE J Biomed Health Inform"},{"issue":"1","key":"2023011917135403000_ref31","first-page":"1","article-title":"A novel heterogeneous network-based method for drug response prediction in cancer cell lines","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"issue":"suppl_2","key":"2023011917135403000_ref32","doi-asserted-by":"crossref","first-page":"W623","DOI":"10.1093\/nar\/gkp456","article-title":"Pubchem: a public information system for analyzing bioactivities of small molecules","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2023011917135403000_ref33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anticancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nature cancer"},{"key":"2023011917135403000_ref34","article-title":"Recent advances in autoencoder-based representation learning","author":"Tschannen","year":"2018"},{"key":"2023011917135403000_ref35","volume-title":"Proceedings of ICML Workshop on Unsupervised and Transfer Learning","author":"Baldi"},{"issue":"1","key":"2023011917135403000_ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-021-04298-y","article-title":"A neural network-based method for polypharmacy side effects prediction","volume":"22","author":"Masumshah","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"2023011917135403000_ref37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1109\/JAS.2021.1004311","article-title":"Sampling methods for efficient training of graph convolutional networks: a survey","volume":"9","author":"Liu","year":"2021","journal-title":"IEEE\/CAA J Autom Sin"},{"key":"2023011917135403000_ref38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1145\/3292500.3330912","volume-title":"Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining","author":"Han","year":"2019"},{"issue":"6","key":"2023011917135403000_ref39","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab165","article-title":"Mda-gcnftg: identifying miRNA-disease associations based on graph convolutional networks via graph sampling through the feature and topology graph","volume":"22","author":"Chu","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023011917135403000_ref42","first-page":"1725","volume-title":"International Conference on Machine Learning","author":"Chen","year":"2020"},{"key":"2023011917135403000_ref102","article-title":"Predicting drug\u2013disease associations through layer attention graph convolutional network","volume":"22","author":"","journal-title":"Brief Bioinform"},{"key":"2023011917135403000_ref40","article-title":"Semi-supervised classification with graph convolutional networks","author":"Kipf","year":"2016"},{"key":"2023011917135403000_ref41","article-title":"Directed graph convolutional network","author":"Tong","year":"2020"},{"issue":"3","key":"2023011917135403000_ref43","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac100","article-title":"Deeptta: a transformer-based model for predicting cancer drug response","volume":"23","author":"Jiang","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023011917135403000_ref44","first-page":"9267","volume-title":"Proceedings of the IEEE\/CVF International Conference on Computer Vision","author":"Li","year":"2019"},{"issue":"3","key":"2023011917135403000_ref45","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"issue":"7","key":"2023011917135403000_ref46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/138955708784567430","article-title":"The development of pro-apoptotic cancer therapeutics","volume":"8","author":"Ziedan","year":"2008","journal-title":"Mini-Rev Med Chem"},{"issue":"3","key":"2023011917135403000_ref47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2010.04.024","article-title":"Metronomic small molecule inhibitor of bcl-2 (tw-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation","volume":"78","author":"Zeitlin","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2023011917135403000_ref48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23610","article-title":"Retracted: Tw-37, a small-molecule inhibitor of bcl-2, inhibits cell growth and invasion in pancreatic cancer","volume":"123","author":"Wang","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"2023011917135403000_ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-015-0130-x","article-title":"Small-molecule inhibitor of bcl-2 (tw-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells","volume":"8","author":"Wang","year":"2015","journal-title":"J Ovarian Res"},{"issue":"10","key":"2023011917135403000_ref50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184501","article-title":"The preclinical analysis of tw-37 as a potential anti-colorectal cancer cell agent","volume":"12","author":"Lei","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2023011917135403000_ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42826-019-0028-7","article-title":"Antitumor effect of tw-37, a bh3 mimetic in human oral cancer","volume":"35","author":"Ahn","year":"2019","journal-title":"Lab Anim Res"},{"issue":"1","key":"2023011917135403000_ref52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett"},{"issue":"4","key":"2023011917135403000_ref53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5732\/cjc.011.10290","article-title":"Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells","volume":"31","author":"Pan","year":"2012","journal-title":"Chin J Cancer"},{"issue":"8329","key":"2023011917135403000_ref54","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(83)91385-5","article-title":"Controlled trial of adjuvant chemotherapy with melphalan for breast cancer","volume":"321","author":"Rubens","year":"1983","journal-title":"Lancet"},{"issue":"10","key":"2023011917135403000_ref55","first-page":"1157","article-title":"Treatment of ovarian cancer at the crossroads: 50 years after single-agent melphalan chemotherapy","volume":"20","author":"Steven","year":"2006","journal-title":"Oncology"},{"issue":"1","key":"2023011917135403000_ref56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08865140208629702","article-title":"Critical evaluation of dichlorvos\u2019 breast cancer risk","volume":"8","author":"Gandhi","year":"2002","journal-title":"Comments Toxicol"},{"key":"2023011917135403000_ref57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphys.2013.00185","article-title":"Membrane potential and cancer progression","volume":"4","author":"Yang","year":"2013","journal-title":"Front Physiol"},{"issue":"3","key":"2023011917135403000_ref58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12015-009-9080-2","article-title":"Role of membrane potential in the regulation of cell proliferation and differentiation","volume":"5","author":"Sundelacruz","year":"2009","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"2023011917135403000_ref59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"2023011917135403000_ref60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2017.18","article-title":"The calcium\u2013cancer signalling nexus","volume":"17","author":"Monteith","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2023011917135403000_ref61","article-title":"Role of tyrosine phosphorylation in modulating cancer cell metabolism","volume":"1874","author":"Taddei","year":"2020","journal-title":"Biochim Biophys Acta (BBA)-Rev Cancer"},{"issue":"1","key":"2023011917135403000_ref62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nbt0105-36","article-title":"An enriched look at tyrosine phosphorylation","volume":"23","author":"Conrads","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2023011917135403000_ref63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2023011917135403000_ref64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2023011917135403000_ref65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-019-0046-z","article-title":"Synthetic lethality as an engine for cancer drug target discovery","volume":"19","author":"Huang","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"2023011917135403000_ref66","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41571-018-0055-6","article-title":"Synthetic lethal therapies for cancer: what\u2019s next after PARP inhibitors?","volume":"15","author":"Ashworth","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"2023011917135403000_ref67","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","article-title":"Synthetic lethality in cancer therapeutics: the next generation","volume":"11","author":"Setton","year":"2021","journal-title":"Cancer Discov"},{"issue":"3","key":"2023011917135403000_ref68","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac106","article-title":"Computational methods, databases and tools for synthetic lethality prediction","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"issue":"1","key":"2023011917135403000_ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00956-5","article-title":"Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation","volume":"13","author":"Topatana","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"D1","key":"2023011917135403000_ref70","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"Synlethdb: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","author":"Guo","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2023011917135403000_ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10744-6","article-title":"A genome-wide positioning systems network algorithm for in silico drug repurposing","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"issue":"12","key":"2023011917135403000_ref72","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (msigdb) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"2023011917135403000_ref73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pestbp.2014.12.003","article-title":"Thiram activates nf-kappab and enhances icam-1 expression in human microvascular endothelial hmec-1 cells","volume":"118","author":"Kurpios-Piec","year":"2015","journal-title":"Pest Biochem Physiol"},{"key":"2023011917135403000_ref74","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3389\/fimmu.2018.02386","article-title":"Immunoproteasome inhibition impairs t and b cell activation by restraining erk signaling and proteostasis","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"2023011917135403000_ref75","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbrc.2017.01.140","article-title":"Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mtor inhibition","volume":"484","author":"Chen","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2023011917135403000_ref76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopha.2012.02.003","volume":"66","author":"Zhu","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"2023011917135403000_ref77","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/neuonc\/nov083","article-title":"Phase i dose-escalation study of the pi3k\/mtor inhibitor voxtalisib (sar245409, xl765) plus temozolomide with or without radiotherapy in patients with high-grade glioma","volume":"17","author":"Wen","year":"2015","journal-title":"Neuro Oncol"},{"key":"2023011917135403000_ref78","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/CMAR.S265788","article-title":"Synergistic effects of tw-37 and abt-263 on renal cell carcinoma cells","volume":"13","author":"Rui","year":"2021","journal-title":"Cancer Manage Res"},{"issue":"2","key":"2023011917135403000_ref79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s43018-020-00169-2","article-title":"Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients","volume":"2","author":"Ma","year":"2021","journal-title":"Nat Cancer"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/1\/bbac501\/48781899\/bbac501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/1\/bbac501\/48781899\/bbac501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:43:16Z","timestamp":1674150196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbac501\/6865039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbac501","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2022,12,2]]},"article-number":"bbac501"}}